NCT06275724 - Specified Drug-use Survey of Leqvio for s.c. Injection. | Biotech Hunter

Enrollment

583

Participants

Timeline

Start Date

March 4, 2024

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions

Familial HypercholesterolaemiaHypercholesterolaemia

Interventions

OTHER

inclisiran

Prospective observational study. There is no treatment allocation. Patients prescribed with inclisiran are eligible to enroll into this study.

Trial Locations (107)

3510021

Novartis Investigative Site, Asaka

7320053

Novartis Investigative Site, Hiroshima

475-0817

Novartis Investigative Site, Handa

491-8551

Novartis Investigative Site, Ichinomiya

494-0001

Novartis Investigative Site, Ichinomiya

485-8520

Novartis Investigative Site, Komaki

454-0933

Novartis Investigative Site, Nagoya

461-0045

Novartis Investigative Site, Nagoya

470 1192

Novartis Investigative Site, Toyoake

496-0038

Novartis Investigative Site, Tsushima

289-2511

Novartis Investigative Site, Asahi

270-1694

Novartis Investigative Site, Inzai

279-0021

Novartis Investigative Site, Urayasu

791-8016

Novartis Investigative Site, Matsuyama

814 0180

Novartis Investigative Site, Fukuoka

800-0031

Novartis Investigative Site, Kitakyushu

807-8556

Novartis Investigative Site, Kitakyushu

960 1295

Novartis Investigative Site, Fukushima

963-8501

Novartis Investigative Site, Kōriyama

961-0005

Novartis Investigative Site, Shirakawa

737-0023

Novartis Investigative Site, Kure

078-8211

Novartis Investigative Site, Asahikawa

078-8214

Novartis Investigative Site, Asahikawa

004-0052

Novartis Investigative Site, Sapporo

062-0003

Novartis Investigative Site, Sapporo

065-0027

Novartis Investigative Site, Sapporo

660-8511

Novartis Investigative Site, Amagasaki

670-8560

Novartis Investigative Site, Himeji

654-0026

Novartis Investigative Site, Kobe

675-1327

Novartis Investigative Site, Ono

665-0873

Novartis Investigative Site, Takarazuka

314-0146

Novartis Investigative Site, Kamisu

306-0232

Novartis Investigative Site, Koga

310-0015

Novartis Investigative Site, Mito

302-0102

Novartis Investigative Site, Moriya

305-8576

Novartis Investigative Site, Tsukuba

920 8641

Novartis Investigative Site, Kanazawa

252-0802

Novartis Investigative Site, Fujisawa

224-8503

Novartis Investigative Site, Yokohama

235-0016

Novartis Investigative Site, Yokohama

238-8567

Novartis Investigative Site, Yokosuka

240-0101

Novartis Investigative Site, Yokosuka

866-8533

Novartis Investigative Site, Yatsushiro

602-8566

Novartis Investigative Site, Kyoto

610-0334

Novartis Investigative Site, Kyōtanabe

514-8507

Novartis Investigative Site, Tsu

856-8562

Novartis Investigative Site, Ōmura

636-0802

Novartis Investigative Site, Ikoma

634-0045

Novartis Investigative Site, Kashihara

632-8552

Novartis Investigative Site, Tenri

940-8621

Novartis Investigative Site, Nagaoka

870-0263

Novartis Investigative Site, Ōita

710-8602

Novartis Investigative Site, Kurashiki

700-8558

Novartis Investigative Site, Okayama

901-2102

Novartis Investigative Site, Urasoe

904-2293

Novartis Investigative Site, Uruma

598-8577

Novartis Investigative Site, Izumisano

570-8507

Novartis Investigative Site, Moriguchi

540-0006

Novartis Investigative Site, Osaka

543-8555

Novartis Investigative Site, Osaka

569-0852

Novartis Investigative Site, Takatsuki

569-1121

Novartis Investigative Site, Takatsuki

569-8686

Novartis Investigative Site, Takatsuki

560-0083

Novartis Investigative Site, Toyonaka

361-0056

Novartis Investigative Site, Gyōda

350-0495

Novartis Investigative Site, Iruma-gun

364-8501

Novartis Investigative Site, Kitamoto

340-0043

Novartis Investigative Site, Sōka

359-1142

Novartis Investigative Site, Tokorozawa

526-8580

Novartis Investigative Site, Nagahama

410-2295

Novartis Investigative Site, Izunokuni

321-4306

Novartis Investigative Site, Mooka

192-0918

Novartis Investigative Site, Hachiōji

194-0021

Novartis Investigative Site, Machida

153-8515

Novartis Investigative Site, Meguro City

106-0031

Novartis Investigative Site, Minato

176-8530

Novartis Investigative Site, Nerima-ku

160-8488

Novartis Investigative Site, Shinjuku

162 8666

Novartis Investigative Site, Shinjuku Ku

130-8575

Novartis Investigative Site, Sumida City

171-0014

Novartis Investigative Site, Toshima-ku

939-1104

Novartis Investigative Site, Takaoka

648-0005

Novartis Investigative Site, Hashimoto

998-8501

Novartis Investigative Site, Sakata

010-8577

Novartis Investigative Site, Akita

261-0024

Novartis Investigative Site, Chiba

910-8526

Novartis Investigative Site, Fukui

811-0213

Novartis Investigative Site, Fukuoka

815-0082

Novartis Investigative Site, Fukuoka

960-8611

Novartis Investigative Site, Fukushima

500-8384

Novartis Investigative Site, Gifu

671-1227

Novartis Investigative Site, Himeji

890-8760

Novartis Investigative Site, Kagoshima

892-0853

Novartis Investigative Site, Kagoshima

861-4193

Novartis Investigative Site, Kumamoto

607-8062

Novartis Investigative Site, Kyoto

612-8555

Novartis Investigative Site, Kyoto

850-8555

Novartis Investigative Site, Nagasaki

852-8055

Novartis Investigative Site, Nagasaki

630-8581

Novartis Investigative Site, Nara

543-8922

Novartis Investigative Site, Osaka

545-8586

Novartis Investigative Site, Osaka

558-8558

Novartis Investigative Site, Osaka

870-1133

Novartis Investigative Site, Ōita

879-7761

Novartis Investigative Site, Ōita

422-8527

Novartis Investigative Site, Shizuoka

990 9585

Novartis Investigative Site, Yamagata